180 Life Sciences Corp (ATNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 731 | 934 | 1,567 | 20,076 | 226 |
| Operating Income | -731 | -934 | -1,567 | -20,076 | -226 |
| Interest Expense | 106 | 194 | 173 | 0 | 0 |
| Other Income | 3 | 1,391 | -647 | -5,744 | 255 |
| Pre-tax Income | -835 | 262 | -2,386 | -25,820 | 30 |
| Income Tax | -5 | 5 | 5 | -227 | 51 |
| Net Income Continuous | -829 | 258 | -2,392 | -25,593 | -22 |
| Net Income | $-829 | $267 | $-2,392 | $-25,593 | $-22 |
| EPS Basic Total Ops | -19.01 | 7.60 | -53.23 | -893.54 | -3.80 |
| EPS Basic Continuous Ops | -18.72 | 5.81 | -53.99 | -893.55 | -1.94 |
| EPS Diluted Total Ops | -19.01 | 7.60 | -53.23 | -878.33 | -3.80 |
| EPS Diluted Continuous Ops | -18.72 | 5.64 | -53.99 | -878.65 | -1.94 |
| EBITDA(a) | $-700 | $-904 | $-1,535 | $-20,076 | $-226 |